vs
Idexx Laboratories（IDXX）とBVSエンターテイメント（RPM）の財務データ比較。上の社名をクリックして会社を切り替えられます
BVSエンターテイメントの直近四半期売上が大きい（$1.9B vs $1.1B、Idexx Laboratoriesの約1.8倍）。Idexx Laboratoriesの純利益率が高く（22.8% vs 8.4%、差は14.3%）。Idexx Laboratoriesの前年同期比売上増加率が高い（14.3% vs 3.5%）。Idexx Laboratoriesの直近四半期フリーキャッシュフローが多い（$326.3M vs $296.4M）。過去8四半期でBVSエンターテイメントの売上複合成長率が高い（12.0% vs 6.4%）
IDEXXラボラトリーズは1983年設立の米国多国籍企業で、伴侶動物獣医療、家畜・家禽、水質検査、乳製品分野向けの製品・サービスの開発・製造・流通を手がけています。本社はメイン州ウェストブルックにあり、EMEA地域の拠点はオランダのホーフドルプに置かれています。
BVSエンターテイメントは旧称サバン・プロダクション、サバン・インターナショナル、サバン・エンターテイメントで、ウォルト・ディズニー・カンパニーの子会社です。1980年4月24日にハイム・サバンとシュキ・レヴィにより音楽制作会社として設立された後、テレビ番組の制作・配給事業へ移行し、Fox Family/ABC Familyや廃止されたFox Kids、Jetix向けの子供向け番組を手がけることで広く知られています。
IDXX vs RPM — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.1B | $1.9B |
| 純利益 | $248.2M | $161.2M |
| 粗利率 | 60.3% | 40.8% |
| 営業利益率 | 28.9% | 11.0% |
| 純利益率 | 22.8% | 8.4% |
| 売上前年比 | 14.3% | 3.5% |
| 純利益前年比 | 14.8% | -12.0% |
| EPS（希薄化後） | $3.09 | $1.26 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.1B | $1.9B | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $998.4M | $1.5B | ||
| Q4 24 | $954.3M | $1.8B | ||
| Q3 24 | $975.5M | $2.0B | ||
| Q2 24 | $1.0B | $2.0B | ||
| Q1 24 | $964.1M | $1.5B |
| Q4 25 | $248.2M | $161.2M | ||
| Q3 25 | $274.6M | $227.6M | ||
| Q2 25 | $294.0M | $225.8M | ||
| Q1 25 | $242.7M | $52.0M | ||
| Q4 24 | $216.1M | $183.2M | ||
| Q3 24 | $232.8M | $227.7M | ||
| Q2 24 | $203.3M | $180.6M | ||
| Q1 24 | $235.6M | $61.2M |
| Q4 25 | 60.3% | 40.8% | ||
| Q3 25 | 61.8% | 42.3% | ||
| Q2 25 | 62.6% | 42.4% | ||
| Q1 25 | 62.4% | 38.4% | ||
| Q4 24 | 59.8% | 41.4% | ||
| Q3 24 | 61.1% | 42.5% | ||
| Q2 24 | 61.7% | 41.4% | ||
| Q1 24 | 61.5% | 39.9% |
| Q4 25 | 28.9% | 11.0% | ||
| Q3 25 | 32.1% | 14.1% | ||
| Q2 25 | 33.6% | 11.9% | ||
| Q1 25 | 31.7% | 2.8% | ||
| Q4 24 | 27.4% | 11.5% | ||
| Q3 24 | 31.2% | 14.8% | ||
| Q2 24 | 26.3% | 11.9% | ||
| Q1 24 | 31.0% | 5.5% |
| Q4 25 | 22.8% | 8.4% | ||
| Q3 25 | 24.8% | 10.8% | ||
| Q2 25 | 26.5% | 10.8% | ||
| Q1 25 | 24.3% | 3.5% | ||
| Q4 24 | 22.7% | 9.9% | ||
| Q3 24 | 23.9% | 11.6% | ||
| Q2 24 | 20.3% | 9.0% | ||
| Q1 24 | 24.4% | 4.0% |
| Q4 25 | $3.09 | $1.26 | ||
| Q3 25 | $3.40 | $1.77 | ||
| Q2 25 | $3.63 | $1.76 | ||
| Q1 25 | $2.96 | $0.40 | ||
| Q4 24 | $2.62 | $1.42 | ||
| Q3 24 | $2.80 | $1.77 | ||
| Q2 24 | $2.44 | $1.40 | ||
| Q1 24 | $2.81 | $0.47 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $180.1M | $316.6M |
| 総負債低いほど良い | $450.0M | $2.5B |
| 株主資本純資産 | $1.6B | $3.1B |
| 総資産 | $3.4B | $7.9B |
| 負債/資本比率低いほどレバレッジが低い | 0.28× | 0.80× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $180.1M | $316.6M | ||
| Q3 25 | $208.2M | $297.1M | ||
| Q2 25 | $164.6M | $302.1M | ||
| Q1 25 | $164.0M | $241.9M | ||
| Q4 24 | $288.3M | $268.7M | ||
| Q3 24 | $308.6M | $231.6M | ||
| Q2 24 | $401.6M | $237.4M | ||
| Q1 24 | $397.4M | $248.9M |
| Q4 25 | $450.0M | $2.5B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $617.8M | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | $1.6B | $3.1B | ||
| Q3 25 | $1.6B | $3.1B | ||
| Q2 25 | $1.5B | $2.9B | ||
| Q1 25 | $1.4B | $2.7B | ||
| Q4 24 | $1.6B | $2.7B | ||
| Q3 24 | $1.6B | $2.6B | ||
| Q2 24 | $1.6B | $2.5B | ||
| Q1 24 | $1.6B | $2.3B |
| Q4 25 | $3.4B | $7.9B | ||
| Q3 25 | $3.4B | $7.9B | ||
| Q2 25 | $3.3B | $7.8B | ||
| Q1 25 | $3.2B | $6.6B | ||
| Q4 24 | $3.3B | $6.7B | ||
| Q3 24 | $3.4B | $6.6B | ||
| Q2 24 | $3.4B | $6.6B | ||
| Q1 24 | $3.4B | $6.4B |
| Q4 25 | 0.28× | 0.80× | ||
| Q3 25 | — | 0.87× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.39× | 0.74× | ||
| Q3 24 | — | 0.77× | ||
| Q2 24 | — | 0.79× | ||
| Q1 24 | — | 0.93× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $355.8M | $345.7M |
| フリーキャッシュフロー営業CF - 設備投資 | $326.3M | $296.4M |
| FCFマージンFCF / 売上 | 29.9% | 15.5% |
| 設備投資強度設備投資 / 売上 | 2.7% | 2.6% |
| キャッシュ転換率営業CF / 純利益 | 1.43× | 2.14× |
| 直近12ヶ月FCF直近4四半期 | $1.1B | $582.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $355.8M | $345.7M | ||
| Q3 25 | $402.3M | $237.5M | ||
| Q2 25 | $185.7M | $149.2M | ||
| Q1 25 | $238.0M | $91.5M | ||
| Q4 24 | $262.0M | $279.4M | ||
| Q3 24 | $220.1M | $248.1M | ||
| Q2 24 | $248.3M | $181.2M | ||
| Q1 24 | $198.6M | $173.4M |
| Q4 25 | $326.3M | $296.4M | ||
| Q3 25 | $371.2M | $175.0M | ||
| Q2 25 | $151.6M | $78.2M | ||
| Q1 25 | $207.9M | $33.3M | ||
| Q4 24 | $232.8M | $229.5M | ||
| Q3 24 | $192.0M | $197.3M | ||
| Q2 24 | $215.0M | $105.3M | ||
| Q1 24 | $168.3M | $124.6M |
| Q4 25 | 29.9% | 15.5% | ||
| Q3 25 | 33.6% | 8.3% | ||
| Q2 25 | 13.7% | 3.8% | ||
| Q1 25 | 20.8% | 2.3% | ||
| Q4 24 | 24.4% | 12.4% | ||
| Q3 24 | 19.7% | 10.0% | ||
| Q2 24 | 21.4% | 5.2% | ||
| Q1 24 | 17.5% | 8.2% |
| Q4 25 | 2.7% | 2.6% | ||
| Q3 25 | 2.8% | 3.0% | ||
| Q2 25 | 3.1% | 3.4% | ||
| Q1 25 | 3.0% | 3.9% | ||
| Q4 24 | 3.1% | 2.7% | ||
| Q3 24 | 2.9% | 2.6% | ||
| Q2 24 | 3.3% | 3.8% | ||
| Q1 24 | 3.1% | 3.2% |
| Q4 25 | 1.43× | 2.14× | ||
| Q3 25 | 1.47× | 1.04× | ||
| Q2 25 | 0.63× | 0.66× | ||
| Q1 25 | 0.98× | 1.76× | ||
| Q4 24 | 1.21× | 1.53× | ||
| Q3 24 | 0.95× | 1.09× | ||
| Q2 24 | 1.22× | 1.00× | ||
| Q1 24 | 0.84× | 2.83× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
RPM
| Construction Products Group Segment | $737.4M | 39% |
| Consumer Segment | $638.6M | 33% |
| Performance Coatings Group Segment | $533.8M | 28% |
